* For illustration purpose only
Active Ingredient: Glimepiride
Utilization: Amaryl is an oral blood sugar-lowering drug which belongs to the class of sulfonylureas
Available Dosages: 1mg, 2mg, 3mg and 4mg
Last purchase: 43 minutes ago
There are 23 users looking at this product right now
Amaryl (Glimepiride) is an oral blood sugar-lowering drug which belongs to the class of sulfonylureas. A drug that has a hypoglycemic effect for oral treating. The active substance glimepiride is a stimulant of the secretion and release of insulin from beta cells of the pancreas, increases the sensitivity of muscles and fat to the production and perception of their own insulin. Glimepiride is a new generation sulfonylurea derivative. Amaryl begins to act 2.5 hours after taking.
Indication for use
Amaryl (Glimepiride) can be taken by almost all adults and teenagers over 18 who have type II diabetes mellitus.
Amaryl (Glimepiride) is not recommended to use if you have:
· type 1 diabetes mellitus;
· diabetic ketoacidosis, diabetic precoma and coma;
· severe liver dysfunction;
· severe renal impairment (including patients on hemodialysis);
· lactation (breastfeeding);
· hypersensitivity to glimepiride or other components of the drug.
Dose and usage
Dose of Amaryl (Glimepiride): 2 mg - green oblong flat tablet with a notch on both sides; 3 mg - pale yellow oblong flat tablets with a notch on both sides; 4 mg - light blue oblong flat tablets with a notch on both sides.
At the beginning of treatment, Amaril is prescribed 1 mg 1 time / day. If necessary, the daily dose can be gradually increased (at intervals of 1-2 weeks) and in the following order: 1 mg-2 mg-3 mg-4 mg-6 mg Amaril per day. The maximum recommended daily dose is 6 mg.
Sometimes Amaryl (Glimepiride) can be cause of some side effects: hypoglycemia, headaches, aggression, impaired attention, sensory disturbances, vomiting, nausea, pain in the gastrointestinal tract, cold sweat
Your doctor should be notified about your health problems.
Medically reviewed by Dr. Josette Davignon
Last updated: 12.04.2021